What is Skin Analytics?
Skin Analytics is a pioneering health-tech enterprise dedicated to improving skin cancer survival rates through its proprietary AI as a Medical Device (AIaMD) platform, known as DERM. The company addresses a critical global health challenge by enabling dermatologist-quality assessments that are both scalable and sustainable for healthcare systems. By reducing the financial and operational burden on clinical providers, Skin Analytics is effectively bridging the gap between patient demand and specialist availability, positioning itself as a leader in the diagnostic AI market.
How much funding has Skin Analytics raised?
Skin Analytics has raised a total of $26.5M across 4 funding rounds:
Grant
$100K
Corporate Investment
$1.2M
Series A
$5.2M
Series B
$19.9M
Grant (2014): $100K with participation from Founder.org
Corporate Investment (2018): $1.2M led by Bristol Private Equity Club
Series A (2020): $5.2M supported by Nesta Holding Co, Hoxton Ventures, and Mustard Seed Venture INC
Series B (2025): $19.9M featuring Intrepid Partners
Key Investors in Skin Analytics
Hoxton Ventures
A London-based early-stage venture capital firm that specializes in scaling European technology startups into global market leaders.
Intrepid Partners
A consultancy and investment firm with extensive experience in project management and financial services, supporting growth-stage enterprises.
Founder.org
A startup investor and company-building program focused on supporting young entrepreneurs in solving complex global challenges through high-impact innovation.
What's next for Skin Analytics?
With the successful closure of its latest funding round, Skin Analytics is well-positioned to accelerate its international expansion and deepen its integration within global health systems. The strategic capital will likely be deployed to enhance the DERM platform's diagnostic accuracy, expand regulatory approvals across new jurisdictions, and scale commercial operations. As the company matures, the focus will shift toward long-term clinical validation and establishing its AI-driven pathways as the standard of care for dermatological screening, ultimately driving sustainable value for both health systems and patients.
See full Skin Analytics company page
